Related Experiment Video
Updated: Jun 6, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children
Yanmei Sang1, Wei Zong, Min Liu
1Department of Endocrinology, Beijing Children's Hospital affiliated to Capital Medical University, Fuxingmenwai Nanlishi Road 56, Beijing, China, 100045. sangyanmei@yahoo.com
Objective:
A functional polymorphism at codon 55 of the small ubiquitin like modifier 4 (SUMO4) gene (methionine to valine; M55V) was recently found to be associated with type 1 diabetes mellitus mainly in Asian populations (T1D). In the present study, we aimed to investigate whether this locus also contributes to the genetic susceptiblity to type 1 diabetes in Chinese.
Research Design And Methods:
A case-control study was performed using genomic DNA samples from 165 unrelated Chinese childhood T1D subjects and 160 normal blood donors. The SUMO4 M55V single nucleotide polymorphism (SNP) was genotyped using polymerase chain reaction (PCR) amplification followed by digestion with the restriction enzyme Mse I.
Results:
The frequencies of SUMO4 163G allele were significantly increased in T1D patients (38. 2% vs. healthy control subjects 28.7%, P < 0.05, OR = 1.51, 95% CI 1.03-2.13). SUMO4 163 GG genotype was also significantly increased in the T1D patients (17% vs. healthy control subjects 8%, P < 0.05).
Conclusions:
This study indicates that the SUMO4 gene M55V variant is associated with the genetic susceptibility of T1D in Chinese children.
Related Concept Videos
Type I Diabetes I: Introduction
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations

